This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of antiretroviral treatment. This test is not intended for use as a screening test for the presence of HIV-1 in blood or blood products or as a diagnostic test to confirm the presence of HIV-1 infection.
3.0 mL Plasma from 2 Lavender Top Tubes - EDTA in a Plastic Vial
42 days Frozen
Separate plasma from cells by centrifugation within 24 hours of collection place in plastic vial and freeze
2.5 mL EDTA
| HIV-1 RNA, Quantitative PCR: | <20 copies/mL | |
| HIV-1 RNA, Quantitative PCR: | <1.30 Log copies/mL | |
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of antiretroviral treatment. This test is not intended for use as a screening test for the presence of HIV-1 in blood or blood products or as a diagnostic test to confirm the presence of HIV-1 infection.
2 to 4 days
00917145
87536